BioWorld

April 21, 2008

View Archived Issues

Biotech's 1st Quarter '08 Fails to Fire Up Market

Read More

Influenza Travel Patterns May Enable Longer-Term Forecasts

Read More

AACR Roundup

Read More

Financings Roundup

Read More

Clinic Roundup

Read More

AAN Roundup

Read More

Other News To Note

Read More

Elan-Wyeth Alzheimer's Trial Suspended Due to Skin Lesion

A Phase II trial of the ACC-011 compound for Alzheimer's disease being developed by Elan Corp. plc and Wyeth Pharmaceuticals has been suspended due to a skin lesion observed in a single patient. (BioWorld Today) Read More

Biotechs Plead Their Case in the Halls of Congress

Read More

Stock Winners and Losers For The Week

Read More

Money Raised By Month

Read More

BioWorld Stock Report For Public Biotechnology Companies

Read More